How big is the DNA Manufacturing Market | Growth Analysis 2025

Code: MTA5151 Publication Date: Jul 2025

How Big Is the DNA Manufacturing Market?

According to 6Wresearch internal database and industry insights, the DNA manufacturing market was estimated at USD 5.8 billion in 2024 and is anticipated to reach over USD 13.9 billion by 2031, growing at a CAGR of 13.5% during the forecast period.

This exponential growth is driven by surging demand for gene therapies, personalized medicine, and the increasing integration of synthetic biology across pharmaceutical and biotech industries.

Growth Factors of the DNA Manufacturing Market

  • Acceleration in gene therapy trials requiring large-scale DNA plasmids and vectors
  • Increasing need for DNA-based vaccines and mRNA platforms
  • Technological innovation in enzymatic DNA synthesis and automation
  • Rising funding and partnerships in genomics and synthetic biology research
  • Need for high-quality DNA in cell therapy and CRISPR applications
  • Outsourcing trends by biotech startups to specialized CDMOs for DNA manufacturing

DNA Manufacturing Market Trends

DNA Manufacturing Market is witnessing a surge in demand owing to rapid advancements in synthetic biology, rising investments in precision medicine, and the evolving landscape of genetic engineering. A key trend is the shift toward cell-free and enzymatic DNA synthesis methods that allow scalable, faster, and contamination-free production. Furthermore, partnerships between pharmaceutical firms and specialized contract manufacturers (CMOs and CDMOs) are reshaping supply chains.

Emerging Developments in DNA Manufacturing Market

In the DNA Manufacturing Market, emerging developments include the integration of AI in optimizing DNA synthesis workflows, rising adoption of automated platforms for error-free gene assembly, and the establishment of modular DNA production facilities to reduce lead times. Companies are also increasingly focused on producing GMP-grade DNA to support clinical applications in gene and cell therapy. In addition to this, academic-industry collaborations are fast-tracking innovation pipelines in synthetic biology and vaccine research.

Leading Companies in the DNA Manufacturing Industry

  • GenScript Biotech Corporation
  • Aldevron (a Danaher company)
  • BioBasic Inc.
  • Thermo Fisher Scientific
  • Twist Bioscience Corporation
  • Codex DNA
  • VGXI Inc.
How big is the DNA Manufacturing Market : FAQ's
VGXI Inc., GenScript Biotech Corporation, Aldevron, Thermo Fisher Scientific, Twist Bioscience Corporation, Codex DNA, and others.
DNA manufacturing market is driven by rising use of DNA in gene therapies, and vaccine development, along with increased funding for genomic research.
DNA manufacturing market is expected to exceed USD 13.9 billion globally by 2031.
Biotech firms, academic researchers, and contract development and manufacturing organizations (CDMOs) are major users.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All